|
Sato Y, Hatakeyama K, Marutsuka K. Incidence of asymptomatic coronary thrombosis and plaque disruption:comparison of non-cardiac and cardiac deaths among autopsy cases [J]. Thrombosis Research, 2009(1):19.
|
|
Newby A C. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2008, (12):2108.
|
|
Goldenberg N, Glueck C. Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk [J]. Vasc Health Risk Manag, 2009(1):369.
|
|
Tziomalos K, Kakafika A I, Athyros V G. The role of statins for the primary and secondary prevention of coronary heart disease in women [J]. Current Pharmaceutical Design, 2009, (10):1054.doi: 10.2174/138161209787846946.
|
|
Antoniades C, Antonopoulos A S, Bendall J K. Targeting redox signaling in the vascular wall:from basic science to clinical practice [J]. Current Pharmaceutical Design, 2009(3):329.doi: 10.2174/138161209787354230.
|
|
Tung P, Wiviott S D, Cannon C P. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22[PROVE IT-TIMI 22] Study) [J]. American Journal of Cardiology, 2009(8):1056.doi: 10.1016/j.amjcard.2008.12.034.
|
|
Adiguzel E, Ahmad P J, Franco C. Collagens in the progression and complications of atherosclerosis [J]. Vascular Medicine, 2009(1):73.
|
|
Olszyński K, Zimowska M. Structure and function of matrix metalloproteinases [J]. Postepy Biochemii, 2009(1):76.
|
|
Jguirim-Souissi I, Jelassi A, Najah M. Metalloproteinases:therapeutic target in atherosclerosis [J]. Tunisie Medicale, 2008(5):490.
|
|
Ott C, Schmieder R E. The role of statins in the treatment of the metabolic syndrome [J]. Current Hypertension Reports, 2009(2):143.doi: 10.1007/s11906-009-0025-6.
|
下载:
苏公网安备 32100302010246号
